0001567619-18-004474.txt : 20181024
0001567619-18-004474.hdr.sgml : 20181024
20181024162526
ACCESSION NUMBER: 0001567619-18-004474
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181017
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Havey Adam
CENTRAL INDEX KEY: 0001514588
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 181136691
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20853
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2018-10-17
2018-10-19
0
0001367644
Emergent BioSolutions Inc.
EBS
0001514588
Havey Adam
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
0
1
0
0
EVP, Business Operations
Common Stock
2018-10-17
4
S
0
314
63.50
D
29253
D
The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
This form 4/A is being filed to amend the sales price of the shares.
/s/ S. Scott Lieberman, Attorney-in-fact
2018-10-24